December 12, 2018 Press release - Regulatory Targovax Presents at DNB 9th Annual Nordic Healthcare Conference
November 28, 2018 Press release - Non-regulatory Targovax is invited to present at upcoming investor and industry conferences
October 26, 2018 Press release - Regulatory Targovax ASA: Announcement of third quarter 2018 financial results
October 15, 2018 Press release - Non-regulatory Targovax reports encouraging disease-free survival (DFS) data from TG01 trial in resected pancreatic cancer
October 12, 2018 Press release - Regulatory Agenda for Targovax Capital Markets Day 15 October 2018, in Oslo, Norway
October 11, 2018 Press release - Regulatory Targovax Key Opinion Leader Symposium on Oncolytic Viruses in New York City today, 11 October, 2018
October 4, 2018 Press release - Regulatory Targovax to host Capital Markets Day 15 October 2018, in Oslo, Norway
October 1, 2018 Press release - Regulatory Targovax presented ONCOS-102 poster at 13th International Adenovirus Meeting
September 27, 2018 Press release - Regulatory Targovax announces interim results from Phase I trial of ONCOS-102 in checkpoint inhibitor refractory melanoma
September 27, 2018 Press release - Regulatory Targovax to Host Key Opinion Leader Symposium on Oncolytic Viruses in New York City, 11 October 2018
September 13, 2018 Press release - Regulatory Targovax strengthens management team with the appointment of Torbjørn Furuseth as CFO; Erik Digman Wiklund to become CBO
September 12, 2018 Press release - Regulatory Targovax announces publication of new oncolytic virus data in the Journal of Medical Virology and Cancer Gene Therapy
September 4, 2018 Press release - Regulatory Targovax ASA: Registration of new share capital following settlement of restricted stock units
August 29, 2018 Press release - Regulatory Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital
August 23, 2018 Press release - Regulatory Targovax ASA: Second quarter and first half year 2018 results
August 15, 2018 Press release - Regulatory Targovax ASA: Invitation to second quarter and first half year 2018 results presentation Thursday 23 August
July 12, 2018 Press release - Regulatory Targovax and SOTIO announce first patient dosed in Phase I/II combination trial of ONCOS-102 with DCVAC
June 20, 2018 Press release - Regulatory Targovax ASA: Mandatory notification of trade – primary insider
June 19, 2018 Press release - Regulatory Targovax granted EU Patent for mutant-RAS neoantigen platform 2nd generation product TG02
June 11, 2018 Press release - Regulatory Targovax strengthens focus on ONCOS oncolytic virus development program
June 4, 2018 Press release - Regulatory Targovax to Present at Jefferies 2018 Global Healthcare Conference
May 24, 2018 Press release - Regulatory Targovax strengthens 2-year survival rate in resected pancreatic cancer with TG01
May 16, 2018 Press release - Regulatory Targovax to present at upcoming investor and industry conferences
May 2, 2018 Press release - Regulatory Targovax announces early signal of efficacy in ONCOS-102 trial in mesothelioma
April 25, 2018 Press release - Regulatory Targovax ASA: Issuance of restricted stock units (RSUs) to the board members
April 25, 2018 Press release - Non-regulatory Targovax presentation at ChinaBio Partnering Forum 2018
April 24, 2018 Press release - Regulatory Targovax ASA: Invitation to first quarter 2018 results presentation Thursday 3 May
April 12, 2018 Press release - Regulatory Targovax strengthens Board of Directors with the appointment of Catherine Wheeler
March 24, 2018 Press release - Regulatory Targovax ASA: Proposal from the nomination committee to the annual general meeting 11 April 2018
March 1, 2018 Press release - Regulatory Targovax ASA: Issuance of restricted stock unites (RSUs) to the chairman of the board of directors
February 7, 2018 Press release - Regulatory Targovax announces completion of safety lead-in and preliminary immune activation data in ONCOS-102 trial in mesothelioma
February 6, 2018 Press release - Regulatory Targovax ASA: Invitation to fourth quarter and full year 2017 results presentation Thursday 15 February
January 8, 2018 Press release - Regulatory Targovax announces the appointment of Michael Bogenstaetter as Chief Business Officer
January 4, 2018 Press release - Regulatory Targovax announces that ONCOS-102 generates immune activation in checkpoint inhibitor refractory melanoma patients
